UC San Diego Health is the first health system in the country to offer a new blood test for testicular cancer, officials announced Monday.

The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap, providing physicians with a sensitive and specific biomarker that informs treatment plans to avoid both under- and over- treating the disease."

"Being able to engage in translational research that radically impacts the way we care for patients with testicular cancer is incredibly rewarding," said Dr. Aditya Bagrodia, professor of urology at UCSD School of Medicine and urologic oncologist at UCSD Health. "Developing this test in partnership with my colleagues represents years of dedicated work to bring a new form of personalized medicine to te

See Full Page